%D8%B9%D9%84%D8%A7%D8%AC_%D8%AC%D9%8A%D9%86%D9%8AGenska_terapijaTer%C3%A0pia_g%C3%A8nica%DA%86%D8%A7%D8%B1%DB%95%D8%B3%DB%95%D8%B1%DA%A9%D8%B1%D8%AF%D9%86%DB%8C_%D8%A8%DB%86%DA%BE%DB%8E%D9%84%DB%8CGenov%C3%A1_terapieGenterapiGentherapie%CE%93%CE%BF%CE%BD%CE%B9%CE%B4%CE%B9%CE%B1%CE%BA%CE%AE_%CE%98%CE%B5%CF%81%CE%B1%CF%80%CE%B5%CE%AF%CE%B1Gene_therapyGenterapioTerapia_g%C3%A9nicaGeeniteraapiaTerapia_genetiko%DA%98%D9%86%E2%80%8C%D8%AF%D8%B1%D9%85%D8%A7%D9%86%DB%8CGeeniterapiaTh%C3%A9rapie_g%C3%A9niqueTerapia_x%C3%A9nica%D7%A8%D7%99%D7%A4%D7%95%D7%99_%D7%92%D7%A0%D7%99%E0%A4%9C%E0%A5%80%E0%A4%A8_%E0%A4%9A%E0%A4%BF%E0%A4%95%E0%A4%BF%E0%A4%A4%E0%A5%8D%E0%A4%B8%E0%A4%BEGenska_terapijaTerapi_jenikG%C3%A9nter%C3%A1piaTerapi_genTerapia_genica%E9%81%BA%E4%BC%9D%E5%AD%90%E6%B2%BB%E7%99%82Terapi_Gen%D0%93%D0%B5%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8F%E0%B2%9C%E0%B3%80%E0%B2%A8%E0%B3%8D%E2%80%8C(%E0%B2%B5%E0%B2%82%E0%B2%B6%E0%B2%B5%E0%B2%BE%E0%B2%B9%E0%B2%BF)_%E0%B2%9A%E0%B2%BF%E0%B2%95%E0%B2%BF%E0%B2%A4%E0%B3%8D%E0%B2%B8%E0%B3%86%EC%9C%A0%EC%A0%84%EC%9E%90_%EC%B9%98%EB%A3%8C%E0%B4%9C%E0%B5%80%E0%B5%BB_%E0%B4%A4%E0%B5%86%E0%B4%B1%E0%B4%BE%E0%B4%AA%E0%B5%8D%E0%B4%AA%E0%B4%BFTerapi_genGentherapieGenterapiTerapia_genowaTerapia_gen%C3%A9tica%D0%93%D0%B5%D0%BD%D0%BE%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8FGenska_terapijaGene_therapyGensko_zdravljenjeGenska_terapija
about
sameAs
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia BIntranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosisTargeted gene therapy of xeroderma pigmentosum cells using meganuclease and TALEN™Gene therapy in Parkinson's disease: rationale and current statusProgress towards gene therapy for cystic fibrosisGene therapy for peripheral arterial diseaseGene therapy for peripheral arterial diseaseGene therapy for haemophiliaGene therapy for sickle cell diseaseGene therapy for haemophiliaGene therapy for sickle cell diseaseGene therapy for sickle cell diseaseGene therapy for sickle cell diseaseGene therapy for peripheral arterial diseaseThe assays of activities and function of TH, AADC, and GCH1 and their potential use in ex vivo gene therapy of PDGOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapyThe atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyDigitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cellsGene therapy rescues cone function in congenital achromatopsia.A new generation of human artificial chromosomes for functional genomics and gene therapyRefined human artificial chromosome vectors for gene therapy and animal transgenesisStem-cell-based gene therapy for HIV infectionVision 1 year after gene therapy for Leber's congenital amaurosisTelomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancerTransfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaAn arrayed human genomic library constructed in the PAC shuttle vector pJCPAC-Mam2 for genome-wide association studies and gene therapyCorrection of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyGene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenGene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administrationLentiviral vectors in gene therapy: their current status and future potentialThe human visual cortex responds to gene therapy-mediated recovery of retinal functionGene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy modelLentiviral vector gene therapy: effective and safe?Newer gene editing technologies toward HIV gene therapyGene therapy for mucopolysaccharidosisGene therapy for ischemic heart diseaseThe Sleeping Beauty transposon system: a non-viral vector for gene therapySuicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytesT cell receptor gene therapy for cancer
P921
Q14754989-3a2856e8-4d6c-7a07-17af-a3c09e385762Q15109846-546a01c9-43cb-1232-acfe-3a827cec676cQ15972056-2a3eadcd-40b7-e53d-ab0b-e969e6c6d8f4Q29887911-ebf7cb9c-4f2f-3a62-a5b4-d4254586036eQ33109869-a7fb9ea2-4aff-58a4-438e-9f9634ee71eeQ56928328-6d401907-4810-526e-d298-7da9b2ca05a2Q88651492-f9cc8540-4178-f538-7fd9-88cdf5b64800
P101
description
Behandlung einer Krankheit dur ...... Körperzellen eines Individuums
@de
terapia a base di geni
@it
therapeutic approach that involves inserting nucleic acids into the patient's cells
@en
Данило ДАУН
@uk
மரபனு சிகிச்சை
@ta
name
Geeniteraapia
@et
Genska terapija
@bs
Genska terapija
@hr
Genska terapija
@sh
Genska terapija
@sr
Gensko zdravljenje
@sl
Genterapi
@da
Gentherapie
@de
Liệu pháp gen
@vi
Terapi Gen
@jv
type
label
Geeniteraapia
@et
Genska terapija
@bs
Genska terapija
@hr
Genska terapija
@sh
Genska terapija
@sr
Gensko zdravljenje
@sl
Genterapi
@da
Gentherapie
@de
Liệu pháp gen
@vi
Terapi Gen
@jv
altLabel
Gene therapy
@it
Gene therapy
@ml
Gene therapy
@ur
Gene-terapia
@eu
Terapia gênica
@pt
Therapie genique
@fr
gena terapio
@eo
genetic enhancement
@en
genetic therapy
@en
genoterapia
@es
prefLabel
Geeniteraapia
@et
Genska terapija
@bs
Genska terapija
@hr
Genska terapija
@sh
Genska terapija
@sr
Gensko zdravljenje
@sl
Genterapi
@da
Gentherapie
@de
Liệu pháp gen
@vi
Terapi Gen
@jv
P227
P2347
P349
P486
P508
P6366
P646
P1051
P1417
topic/gene-therapy
P1461
Gene-Therapy
P227
P2347
P279
P2924
P3219
therapeutique-therapie-genique
therapie-genique-premier-essai
P3417
Gene-Therapy
P349
P3569
levenswetenschappen-en-geneeskunde/gentherapie
P373
Gene therapy
P3827
gene-therapy
genetic-enhancement